Tag: Competition

Displaying 1 - 20 of 3635 results.

Pages

Pharmaceutical and biologic manufacturers Bristol-Myers Squibb Company, or BMS, and Celgene Corporation have agreed to divest Celgene’s Otezla, the most popular oral treatment in the United States for moderate-to-severe psoriasis, for $13.4 billion. This divestiture would settle Federal Trade...
Pharmaceutical and biologic manufacturers Bristol-Myers Squibb Company and Celgene Corporation have agreed to divest Celgene’s Otezla, the most popular oral treatment in the United States for moderate-to-severe psoriasis, for $13.4 billion. The divestiture settles Federal Trade...
The Commission and Department of Justice’s recent case against Canon Inc. and Toshiba Corporation for violating the Hart-Scott-Rodino Antitrust Improvements Act makes an important point: restructuring a deal to avoid or delay an HSR filing may subject the merging companies to...
From: Sheinberg, Samuel I.Sent: Wednesday, September 04, 2019 3:59 PMTo: [Redacted]Cc: [Redacted]Subject: RE: Formation question 801.40/801.50We agree with all three of your points.SamFrom: [Redacted]Sent: Tuesday, September 3, 2019 2:43:23 PM (UTC-05:00) Eastern Time (US & Canada...
[Redacted]Capital gains are not reported. SamFrom: [Redacted]Sent: Wednesday, September 11, 2019 1:41:24 PM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Subject: Item 5 Reporting of Capital GainsHSRHelp,
From: Whitehead, NoraSent: Thursday, September 5, 2019 4:05:13 PM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: RE: Question re: 802.4 / 802.50Confirmed.From: [Redacted]Sent: Thursday, September 5, 2019 3:03:06 PM (UTC-05:00) Eastern Time (US &...
From: Musick, VesselinaSent: Wednesday, September 18, 2019 4:29:28 PM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: RE: Query regarding 803.2 / Certifications
From: Whitehead, Nora Sent: Thursday, September 5, 2019 9:13:40 AM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: RE: Foreign entity - corporation or non-corporate entity
From: Whitehead, NoraSent: Friday, August 2, 2019 9:26:04 AM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: RE: HSR Valuation QuestionIf the cash infusion is consideration for the sale of B to A, then the amount should be included in the size of...
From: Six, AnneSent: Monday, August 19, 2019 3:20:36 PM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: RE: HSR Question - Item 4(c) - Board Presentations[Redacted]Yes, this is still the FTC’s position.
From: Whitehead, NoraSent: Thursday, August 22, 2019 1:20:09 PM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: RE: HSR Debt QuestionYou cannot deduct the repayment of debt in an asset acquisition. This is the case regardless of whether the target has...
From: Six, AnneSent: Friday, August 16, 2019 11:11:38 AM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: RE: Acquisition of Less Than 5% of Shares on Secondary Market[Redacted]Under these facts, 802.9 doesn’t apply.
From: Six, AnneSent: Tuesday, August 13, 2019 2:07:49 PM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: FW: 802.50 / 802.51[Redacted]“Sales” means annual net sales for purposes of 802.50 and 802.51.Best,AnneFrom: [Redacted]Sent: Thursday, August 8, 2019...
From: Whitehead, NoraSent: Wednesday, August 28, 2019 8:59:06 AM (UTC-05:00) Eastern Time (US & Canada)To: [Redacted]Cc: [Redacted]Subject: RE: 802.9 - Competitors
The Federal Trade Commission staff has submitted a comment to Massachusetts State Representative Paul Donato in support of a bill before the Massachusetts legislature, which would allow podiatrists to treat not just the foot, but also the lower leg.

Pages